Ironwood Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US46333X1081

SecurityIRWD / Ironwood Pharmaceuticals, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in IRWD / Ironwood Pharmaceuticals, Inc.

On May 15, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Ironwood Pharmaceuticals, Inc. (US:IRWD) valued at $0 USD as of March 31, 2025. The entity filed a previous 13F-HR on February 14, 2025 disclosing 12,502 shares of Ironwood Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (IRWD) in the form of stock options. The firm currently holds call options representing 15,400 of underlying shares valued at $21,868 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IRWD / Ironwood Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-05-15 2025-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 0 -12,502 -100.00 0 -100.00
2025-02-14 2024-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 12,502 -245 -1.92 55 5.88 0.0001
2024-11-14 2024-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 12,747 12,747 51 0.0001
2024-08-14 2024-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 0 -12,998 -100.00 0 -100.00
2024-05-15 2024-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 12,998 12,998 113 0.0001
2022-02-14 2021-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 0 -21,606 -100.00 0 -100.00
2021-11-12 2021-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 21,606 5,126 31.10 286 36.19 0.0003
2021-08-06 2021-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 16,480 -13,655 -45.31 210 -36.36 0.0003
2021-05-14 2021-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 30,135 16,865 127.09 330 115.69 0.0005
2021-02-12 2020-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 13,270 1,755 15.24 153 41.67 0.0002
2020-11-13 2020-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 11,515 919 8.67 108 0.00 0.0003
2020-08-13 2020-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 10,596 10,596 -7.98 108 0.00 0.0003
2019-05-15 2019-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 0 -25,691 -100.00 0 -100.00
2019-02-13 2018-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 25,691 25,691 255 0.0007
2018-02-14 2017-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 0 -11,236 -100.00 0 -100.00
2017-11-15 2017-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 11,236 11,236 177 0.0007
2016-11-14 2016-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 0 -87 -100.00 0 -100.00
2016-08-15 2016-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 87 87 1 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Call 15,400 22 n/a n/a n/a
2024-08-14 2024-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A Call 52,700 459 n/a n/a n/a
2022-05-16 2022-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A Call 15,900 15.22 186 1.64 n/a n/a n/a
2021-11-12 2021-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Call 13,800 26.61 183 31.65 n/a n/a n/a
2021-08-06 2021-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A Call 10,900 139 n/a n/a n/a
2019-02-13 2018-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Call 19,300 -6.31 356 11.95 n/a n/a n/a
2018-08-13 2018-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A Call 20,600 0.00 318 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A Call 20,600 0.00 318 0.00 n/a n/a n/a
2018-02-14 2017-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Call 17,700 7.27 279 9.84 n/a n/a n/a
2016-11-14 2016-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Call 16,500 -18.72 254 -3.42 n/a n/a n/a
2016-08-17 2016-06-30 13F/A IRONWOOD PHARMACEUTICALS COM CL A Call 20,300 263 n/a n/a n/a
2016-08-15 2016-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A Call 203 263 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 10,100 44 n/a n/a n/a
2024-08-14 2024-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 23,400 204 n/a n/a n/a
2022-05-16 2022-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 12,600 -2.33 147 -14.04 n/a n/a n/a
2021-11-12 2021-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 12,900 -48.81 171 -46.73 n/a n/a n/a
2021-08-06 2021-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 25,200 -27.17 321 -15.30 n/a n/a n/a
2021-05-14 2021-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 34,600 37.30 379 18.07 n/a n/a n/a
2021-02-12 2020-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 14,000 132 n/a n/a n/a
2019-11-14 2019-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-20 2019-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 11,300 124 n/a n/a n/a
2019-05-15 2019-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 32,500 100.62 322 7.69 n/a n/a n/a
2018-11-14 2018-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 16,200 62.00 299 94.16 n/a n/a n/a
2018-08-13 2018-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 10,000 0.00 154 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 10,000 -8.26 154 -5.52 n/a n/a n/a
2018-02-14 2017-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A Put 10,900 -50.68 163 -53.30 n/a n/a n/a
2017-11-15 2017-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 22,100 79.67 349 84.66 n/a n/a n/a
2016-11-14 2016-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 12,300 12,712.50 189 52.42 n/a n/a n/a
2016-08-15 2016-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A Put 96 125 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.